You are using an outdated browser. Please upgrade your browser to improve your experience.

combined oxidative phosphorylation defect type 15

Disease Summary
Associated Targets (1)
Tbio

1


Mondo Description Combined oxidative phosphorylation defect type 15 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by onset in infancy or early childhood of muscular hypotonia, gait ataxia, mild bilateral pyramidal tract signs, developmental delay (affecting mostly speech and coordination) and subsequent intellectual disability. Short stature, obesity, microcephaly, strabismus, nystagmus, reduced visual acuity, lactic acidosis, and a brain neuropathology consistent with Leigh syndrome are also reported.
Uniprot Description An autosomal recessive, mitochondrial, neurologic disorder characterized by features of Leigh syndrome and combined oxidative phosphorylation deficiency. Clinical features include mild global developmental delay, white matter abnormalities, ataxia, incoordination, speech and reading difficulties, T2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem.
Mondo Term and Equivalent IDs
MONDO:0013987:  combined oxidative phosphorylation defect type 15
DOID:0111491: 
Orphanet:319524: 
SCTID:763203009: 
UMLS:C3554182: